Robert Shawah
Oprichter bij ACURX PHARMACEUTICALS, INC.
Vermogen: 474 892 $ op 31-05-2024
Actieve functies van Robert Shawah
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ACURX PHARMACEUTICALS, INC. | Oprichter | 01-07-2017 | - |
| Financieel Directeur/CFO | 01-07-2017 | - | |
| Comptroller/Controller/Auditor | 01-07-2017 | - |
Loopbaan van Robert Shawah
Eerdere bekende functies van Robert Shawah
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Ameri100 Holdco, Inc.
 Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Directeur/Bestuurslid | 01-08-2018 | 01-12-2018 |
Dipexium Pharmaceuticals, Inc.
 Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01-03-2014 | 01-04-2017 |
| Treasurer | 01-03-2014 | 01-04-2017 | |
| Baldwin Pearson & Co., Inc. | Corporate Officer/Principal | 01-01-2005 | 01-01-2013 |
Opleiding van Robert Shawah
| Bucknell University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ACURX PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Health Technology |
Ameri100 Holdco, Inc.
Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Miscellaneous |
| Baldwin Pearson & Co., Inc. |
- Beurs
- Insiders
- Robert Shawah
- Ervaring
